STI Solution

Protect and improve reproductive and sexual health through accurate and early detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoea (NG). The dual target assay provides excellent diagnostic performance across a broad range of specimen types, from both patient and clinician collected samples.¹

Expand your testing capability with qualitative detection and differentiation of Herpes simplex viruses (HSV) 1 and 2. A Nucleic Acid Amplification Test (NAAT) is the preferred testing method for genital herpes diagnosis.^2,3 Distinguishing between HSV 1 and 2 is recommended for all patients with first-episode genital herpes.⁴

Protect sexual health through accurate and early detection of a prevalent and often overlooked STI, Mycoplasma genitalium. Emerging data has brought a new understanding of the prevalence and clinical impact of this bacterium, an infection that is often asymptomatic.⁵ NAATs that identify nucleic acids from Mycoplasma genitalium are the only useful methods for diagnosing infections.^{6, 7}

Global prevalence of Trichomonas vaginalis (TV) infection is estimated to be higher than chlamydia and gonorrhoea combined.⁸ Clinical presentation is an unreliable indicator of TV infection in women, as 10-50% of infections are asymptomatic.⁹ The Aptima TV assay delivers up to 100% detection in both symptomatic and asymptomatic patients.¹⁰

The Hologic high-throughput solution allows you to expand your testing menu while adding on flexibility, capacity and walkaway time. The Panther® System is the foundation of Panther Scalable Solutions. It lets you customise your testing by choosing from a broad assay menu and instrument add-ons, allowing an economical and scalable path to your growth.

The single target assay provides excellent diagnostic performance across a broad range of specimen types, from both patient and clinician collected samples. This assay adds additional testing flexibility by using an alternative target region to the Aptima Combo 2 assay (for CT/NG), providing more confidence in the diagnosis.^11,1

The single target assay provides excellent diagnostic performance across a broad range of specimen types, from both patient and clinician collected samples. This assay adds additional testing flexibility by using an alternative target region than the Aptima Combo 2® assay (for CT/NG), providing more confidence in the diagnosis.^12,1

Hologic's collection devices and specimen transfer tubes support a comprehensive molecular testing portfolio for the Panther and Panther Fusion instrument. Developed for highly accurate and reliable results and simplified workflow.